Fermer le menu


Member of Lyonbiopole


Founded in 2015 by two scientists, Géraldine Le Duc and Pr Olivier Tillement, NH TherAguix is a French biotechnology company based in Grenoble. NH TherAguix has developed an innovative theranostic nanodrug called AGuIX® that allows to fight more efficiently against all forms of cancer.

Thanks to a €13M fund raising in 2019 (BPI, Innobio, Omnes, Arbevel, Supernova), NH THerAguix was able to launch a promising portfolio of clinical trials.


Strategic application domain: Human Medicine

Application market: Oncology

Type of activity: Diagnostics, Therapeutics, Pharma or Biotech

Technologies: Drug delivery device & Technologies, Imaging, Nanotechnology

Created on dec. 15th, 2015 - 12 employees



19 chemin des prés 38240 Meylan



Vous devez être connecté et membre de Lyonbiopôle pour voir les contacts.